These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 6280852)
1. Activity of bis-carbamoyloxymethyl derivatives of pyrroles and pyrrolizines against human tumor xenografts in nude mice. Anderson WK Cancer Res; 1982 Jun; 42(6):2168-70. PubMed ID: 6280852 [TBL] [Abstract][Full Text] [Related]
2. Vinylogous carbinolamine tumor inhibitors. 8. Activity of bis(acyloxymethyl) derivatives of pyrroles and pyrrolizines against a panel of murine leukemias and solid tumors. Anderson WK; Chang CP; Corey PF; Halat MJ; Jones AN; McPherson HL; New JS; Rich AC Cancer Treat Rep; 1982 Jan; 66(1):91-7. PubMed ID: 7053273 [TBL] [Abstract][Full Text] [Related]
3. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic response of human tumor xenografts in athymic mice to doxorubicin. Giuliani FC; Zirvi KA; Kaplan NO Cancer Res; 1981 Jan; 41(1):325-35. PubMed ID: 7448772 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity. McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436 [TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity. Bousquet PF; Braña MF; Conlon D; Fitzgerald KM; Perron D; Cocchiaro C; Miller R; Moran M; George J; Qian XD Cancer Res; 1995 Mar; 55(5):1176-80. PubMed ID: 7867004 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of human tumor xenografts in genetically athymic mice. Ovejera AA; Houchens DP; Barker AD Ann Clin Lab Sci; 1978; 8(1):50-6. PubMed ID: 623430 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice. Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue. Li LH; DeKoning TF; Kelly RC; Krueger WC; McGovren JP; Padbury GE; Petzold GL; Wallace TL; Ouding RJ; Prairie MD Cancer Res; 1992 Sep; 52(18):4904-13. PubMed ID: 1516047 [TBL] [Abstract][Full Text] [Related]
10. Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude mice. Howell SB; Jenkins RS; Streifel J Cancer Res; 1979 Oct; 39(10):3875-80. PubMed ID: 476623 [TBL] [Abstract][Full Text] [Related]
11. Effect of 4'-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice. Giuliani FC; Coirin AK; Rice MR; Kaplan NO Cancer Treat Rep; 1981; 65(11-12):1063-75. PubMed ID: 7296552 [TBL] [Abstract][Full Text] [Related]
12. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878 [TBL] [Abstract][Full Text] [Related]
14. Therapy for mouse tumors and human tumor xenografts with the antitumor antibiotic AT-125. Houchens DP; Ovejera AA; Sheridan MA; Johnson RK; Bogden AE; Neil GL Cancer Treat Rep; 1979 Mar; 63(3):473-6. PubMed ID: 427827 [TBL] [Abstract][Full Text] [Related]
15. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044 [TBL] [Abstract][Full Text] [Related]
17. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas. Fodstad O; Aamdal S; Pihl A; Boyd MR Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640 [TBL] [Abstract][Full Text] [Related]
18. New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse. Giuliani FC; Kaplan NO Cancer Res; 1980 Dec; 40(12):4682-7. PubMed ID: 7438099 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice. Geiger T; Müller M; Monia BP; Fabbro D Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]